Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer

IMPORTANCE: Surgery followed by adjuvant chemotherapy or chemoradiation is widely used to treat resectable pancreatic cancer. Although studies suggest initiation of adjuvant therapy within 12 weeks of surgery, there is no clear time interval associated with better survival. OBJECTIVE: To evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Sung Jun, Oladeru, Oluwadamilola T., Miccio, Joseph A., Iovoli, Austin J., Hermann, Gregory M., Singh, Anurag K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694394/
https://www.ncbi.nlm.nih.gov/pubmed/31411712
http://dx.doi.org/10.1001/jamanetworkopen.2019.9126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694394/
https://www.ncbi.nlm.nih.gov/pubmed/31411712
http://dx.doi.org/10.1001/jamanetworkopen.2019.9126

Ejemplares similares